Thyroid carcinomas comprise a broad spectrum of tumors with different clinical behaviors. On the one side, there are occult papillary carcinomas (PTC), slow growing and clinically silent, and on the other side, rapidly growing anaplastic carcinomas (ATC), which are among the most lethal human neoplasms. We have analysed the microRNA (miR) profile of ATC in comparison to the normal thyroid using a microarray (miRNACHIP microarray). By this approach, we found an aberrant miR expression profile that clearly differentiates ATC from normal thyroid tissues and from PTC analysed in previous studies. In particular, a significant decrease in miR-30d, miR-125b, miR-26a and miR-30a-5p was detected in ATC in comparison to normal thyroid tissue. These results were further confirmed by northern blots, quantitative reverse transcription-PCR analyses and in situ hybridization. The overexpression of these four miRs in two human ATC-derived cell lines suggests a critical role of miR-125b and miR-26a downregulation in thyroid carcinogenesis, since a cell growth inhibition was achieved. Conversely, no effect on cell growth was observed after the overexpression of miR-30d and miR-30a-5p in the same cells. In conclusion, these data indicate a miR signature associated with ATC and suggest the miR deregulation as an important event in thyroid cell transformation.
Thyroid carcinomas comprise a broad spectrum of tumors with different clinical behaviors. On the one side, there are occult papillary carcinomas (PTC), slow growing and clinically silent, and on the other side, rapidly growing anaplastic carcinomas (ATC), which are among the most lethal human neoplasms. We have analysed the microRNA (miR) profile of ATC in comparison to the normal thyroid using a microarray (miRNACHIP microarray). By this approach, we found an aberrant miR expression profile that clearly differentiates ATC from normal thyroid tissues and from PTC analysed in previous studies. In particular, a significant decrease in miR-30d, miR-125b, miR-26a and miR-30a-5p was detected in ATC in comparison to normal thyroid tissue. These results were further confirmed by northern blots, quantitative reverse transcription-PCR analyses and in situ hybridization. The overexpression of these four miRs in two human ATC-derived cell lines suggests a critical role of miR-125b and miR-26a downregulation in thyroid carcinogenesis, since a cell growth inhibition was achieved. Conversely, no effect on cell growth was observed after the overexpression of miR-30d and miR-30a-5p in the same cells. In conclusion, these data indicate a miR signature associated with ATC and suggest the miR deregulation as an important event in thyroid cell transformation. Keywords: microRNA; miR-30d; miR-125b; miR-26a; miR-30a-5p; thyroid anaplastic carcinoma MicroRNAs (miRs) are B22 nt small non-coding, single-stranded RNAs that constitute a novel class of gene regulators (Bartel, 2004) . It has been found that they are abnormally expressed in diverse cancer subtypes like chronic lymphocytic leukemia (Calin et al., 2002 (Calin et al., , 2005 ), Burkitt's lymphoma (Metzler et al., 2004) , colorectal cancer (Michael et al., 2003) , lung cancer (Takamizawa et al., 2004) , breast cancer (Iorio et al., 2005) and glioblastoma (Chan et al., 2005) .
Recently, analysing the miR genome-wide expression profile in human thyroid papillary carcinomas (PTC) using a miRNACHIP microarray, we and another group found an aberrant miR expression profile that clearly separates PTC versus normal thyroid tissues (He et al., 2005; Pallante et al., 2006) . In particular, a significant increase in miR-221, miR-222 and miR-181b was detected in PTC in comparison to normal thyroid tissue and functional studies demonstrated that at least the miR-221 plays an important role in thyroid cell proliferation (Pallante et al., 2006) . More recently, it has been shown that miR-197 and miR-346, were significantly overexpressed in follicular thyroid carcinomas (FTC) (Weber et al., 2006) . However, thyroid carcinomas also include very aggressive tumors such as the poorly differentiated (PDC) and the anaplastic carcinomas (ATC) (Kondo et al., 2006) . These constitute 1-7% of all human thyroid cancer cases; they are rapidly growing and represent one of the most lethal human neoplasms (Kondo et al., 2006) . PDC and ATC seem to derive from the progression of PTC and follicular differentiated carcinomas (Hunt et al., 2003; Kondo et al., 2006) . This progression process is expected to require multiple changes in the expression of several genes. Some of these genes may be overexpressed in the ATC compared to the differentiated tumors as demonstrated for c-myc (Cerutti et al., 1996) , b10 thymosin and HIP (De Nigris et al., 1998) . Some others correspond to genes silenced or to genes, whose function is impaired by gene mutation. In fact, alterations of the p53 tumor suppressor gene are a peculiar feature of most ATC (Donghi et al., 1993; Fagin et al., 1993) . However, this progression seems to require the loss of function of other genes that negatively regulate thyroid cell proliferation. In fact, we have reported that cell hybrids deriving from the fusion of ATC and PTC or FTC cell lines (all of them lacking p53 function) did not show the malignant phenotype, being unable to grow in agar and induce tumors in athymic mice (Martelli et al., 2000) .
Therefore, the analysis of the miR profile in ATC would give precious information to identify additional molecular differences between PTC and ATC. Moreover, since the ATC are characterized by the loss of the typical thyroid functions (Ros et al., 1999) , that is thyroglobulin synthesis/secretion and iodine trapping, and since miRs are frequently involved in the differentiation process (Liu et al., 2004; Sempere et al., 2004) , this analysis might also lead to the identification of genes potentially involved in the regulation of the thyroid differentiative processes.
On the basis of these considerations, we have analysed the genome-wide miR expression profile in 10 human ATC samples versus 10 normal thyroid tissue samples using a miRNACHIP microarray (Liu et al., 2004) . By the mean of the analysis of variance, we obtained a list of differentially expressed miRs (Po0.05) between normal and neoplastic thyroids (Table 1) . Some miRs were significantly changed in their expression level between neoplastic tissues and normal ones: considering a cutoff of twofold upregulation or downregulation, we obtained 10 miR genes modulated (Table 1) . Surprisingly, all these 10 modulated miRs showed a negative fold change (four of them showed a negative fold change higher than threefold, they are miR-30d, miR-125b, miR-26a and miR-30a-5p) and, by these criteria, no miR was upregulated.
It is important to state that two mature miRs (miR30a-5p and miR-30a-3p, http://microrna.sanger.ac.uk/ sequences/index.shtml) originate from miR-30a precursor. No significant change in miR-30a-3p expression was observed; therefore, this miR was not further analysed in this study.
To confirm the results of the microarray analysis we performed northern blot analysis on a limited number of ATC samples using probes corresponding to miR-30d, miR-125b, miR-26a and miR-30a-5p ( Figure 1a Since miR-30d and miR-30a-5p show a highly related sequence (http://microrna.sanger.ac.uk/sequences/index.shtml), a northern blot analysis has been performed on HEK293 cells transfected with pre-miR negative control, pre-miR-30d and pre-miR-30a-5p to demonstrate the specificity of the probes (Figure 1a , lower panel).
Next, we used quantitative reverse transcription (qRT)-PCR to evaluate the expression of these four miRs in a panel of 20 ATC samples, different from those Figure 1b , all these miRs were downregulated in almost all the carcinoma samples. These results confirm that the decreased expression of some miRs is strictly associated with human ATC. To verify that the miR downregulation was effectively restricted to the tumor cells in the sample, we set up an ISH assay for the miR analysis directly onto the neoplastic tissue sections. We analysed ATC slides for the expression of miR-30d. As shown in Figure 1c , ISH technique also confirmed the downregulation of miR30d in the ATC samples compared to normal thyroid tissue slides. In fact, a clear positive hybridization signal was present in the normal thyroid tissue, while it was absent in the ATC tissues. No signal was obtained both in normal thyroid and carcinoma tissue when they were hybridized with a negative control (Scramble-ISH, Exiqon A/S, Vedbaek, Denmark) probe (data not shown). Therefore, it is clear that undifferentiated thyroid carcinomas and ATCs also are characterized by an aberrant expression of miRs.
It is interesting to observe that the comparison between the miR profile of PTC and ATC samples does not show any significant similarity. In fact, the miR-221 and miR-222, highly upregulated in PTCs (Pallante et al., 2006) , did not result upregulated at all in ATC.
Only the miR-222 shows an increase in ATC but of lower proportion. This would apparently exclude the derivation of ATC from PTC through a mechanism of cancer progression. However, we have to consider that the passage from the differentiated to undifferentiated phenotype may involve several genetic alterations that could completely modify the miR expression profile of the ATC.
Interestingly, we have always found a downregulation of miRs in ATC samples, whereas no miR has been found significantly upregulated. Intriguingly, previously published data on PTC (He et al., 2005; Pallante et al., 2006) show an opposite result: several miRs were drastically upregulated, whereas only few miRs were downregulated with a low fold change. These results would suggest the downregulated miRs in ATC can function as tumor suppressor or differentiation genes. These data would also be consistent with our previous data that indicate recessivity of the ATC phenotype (Martelli et al., 2000) .
MiRs downregulation has also been observed in mouse models of thyroid carcinogenesis. Transgenic mice expressing SV40 large T oncogene under the transcriptional control of the thyroglobulin (Tg) promoter develop undifferentiated thyroid carcinomas (Ledent et al., 1991) : these tumors have been analysed for the expression of miR-30d, miR-125b, miR-26a and miR-30a-5p, by qRT-PCR analysis. As shown in the Figure 2 , the expression levels of these miRs decrease in all the mouse ATC tissues in comparison to the normal thyroid tissue. Therefore, the analysis of the SV40 large T model of thyroid carcinogenesis seems to confirm that the decreased expression of these miRs is related to the undifferentiated histotype of thyroid cancer.
The aberrant expression of some miRs in ATC prompted us to investigate whether their downregulation could affect the thyroid cell proliferation. To this purpose, we selected miR-30d, miR-125b, miR-26a and miR-30a-5p for functional studies. We transiently restored their function by transfecting them in FB-1 and FRO cell lines. MiRs expression was confirmed by qRT-PCR ( Figure 3a) . As shown in Figure 3b , miR125b and miR-26a were able to reduce the proliferation rate by 40% in the FB-1 cells after 72 h with respect to the same cells transfected with the pre-miR negative control (pre-miR with a random sequence from Ambion, Austin, TX, USA). Similar results, even if to a less extent, were obtained performing the experiment in the FRO cells (Figure 3c ). It is noteworthy to observe that no cellular death was detected by staining with Trypan blue, excluding an apoptotic effect. Conversely, no effect on the cell growth, in comparison to the control transfected cells, was observed when miR-30d and miR-30a-5p were transfected on the same ATC cell lines (Figures 3b and c) . This result would suggest that Figure 2 mirVana qRT-PCR analysis of miR expression in mouse models of thyroid carcinogenesis. A panel of ATC arising in transgenic mice expressing large T SV40 oncogene under the transcriptional control of the thyroglobulin (Tg) promoter were tested for miR expression. Normal mouse thyroid tissues were used as controls. The fold change values indicate the relative change in the expression levels between tumor and normal thyroid samples, assuming that the value of each normal sample was equal to 1. Figure 1 Anaplastic thyroid carcinoma miR expression profile. (a) Upper panel: northern blot analysis was performed on human ATC and PTC samples as described previously (Pallante et al., 2006) with minor modifications (the membranes were washed at 601C: two times with 2 Â SSPE/0.1% sodium dodecyl sulfate (SDS) and two times with 0.5 Â SSPE/0.1% SDS). The probes used correspond to the complementary sequences of the mature miR-30d, miR-125b, miR-26a and miR-30a-5p. miR-30d-probe 5 0 -CTTCCAGTCGGGGATGTTTACA-3 0 ; miR-125b-probe 5 0 -TCACAAGTTAGGGTCTCAGGGA-3 0 ; miR-26a-probe 5 0 -GCCTATCCTGGATTACTTGAA-3 0 ; miR-30a-5p-probe 5 0 -CTTCCAGTCGAGGATGTTTACA-3 0 . An oligonucleotide complementary to the U6 RNA (Pallante et al., 2006) was used for normalization of the expression levels in the different samples. Lower panel: to demonstrate the specificity of the probes, northern blot analysis has been performed on HEK293 cells transfected with the RNA oligonucleotides corresponding to pre-miR negative control (#AM17110, Ambion), pre-miR-30d and pre-miR-30a-5p (Ambion), and hybridized with the probes as indicated. Human neoplastic thyroid tissues and normal adjacent tissue or the contralateral normal thyroid lobe (Department of Pathology, University of Verona, Italy and Department of Pathology, University of Bologna -Ospedale Bellaria, Bologna, Italy) were obtained from surgical specimens and immediately frozen in liquid nitrogen. Total RNA isolation was performed with Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. RNA was also extracted from paraffinembedded archive materials with Optimum FFPE RNA Isolation Kit (Ambion) according to the manufacturer's instructions. The integrity of the RNA was assessed by denaturing agarose gel electrophoresis. (b) qRT-PCR analysis was performed on a panel of ATC samples of human thyroid origin by using AmpliTaq DNA Polymerase (Applied Biosystems, Foster City, CA, USA) and the mirVana qRT-PCR miRNA Detection Kit (Ambion) following the manufacturer's instructions. Reactions contained mirVana qRT-PCR Primer Sets (Ambion) specific for miR-30d, miR-125b, miR-26a, miR-30a-5p and U6 for normalization. The relative amount of each miR was normalized to the U6 RNA using the 2
ÀDCt method (Pallante et al., 2006) and the fold change values indicate the relative change in the expression levels between tumor samples and normal samples, assuming that the value of each normal sample was equal to 1. (c) In situ hybridization of miR-30d was performed on paraffin-embedded ATC and normal thyroid slides. The signal corresponding to miR-30d expression clearly disappears in ATC as indicated using DIG-labeled LNA probes and horseradish peroxidase (HRPO)-conjugated anti DIG antibody. The in situ hybridisation (ISH) protocol, freely available on the web (http://www.exiqon.com/uploads/LNA_52-_FFPE_miRNA_in_situ_protocol.pdf), was used with minor modifications (10% paraformaldehyde for samples fixation, 65% formamide in the hybridization buffer, hybridization temperature of 49.51C, detection was based on the HRPO). As negative control, we used Scramble-ISH miRCURY LNA Detection probe 3 0 -DIG-labeled (Exiqon A/S), a probe that has no known miRNA targets. ATC, anaplastic thyroid carcinoma; miR, microRNA; NT, normal thyroid; PTC, papillary thyroid carcinoma. miR-125b and miR-26a downregulation could have an important role in thyroid carcinoma cell proliferation, whereas a role of the other miRs in thyroid differentiation may be hypothesized.
The reported effect of miR-125b on the thyroid carcinoma cell proliferation here differs from previous findings (Lee et al., 2005) showing that the suppression of miR-125b, by antisense sequences, is able to decrease the cell growth. MiR-125b has a different expression in the human tumors, that is it is upregulated in pancreas and stomach carcinomas and downregulated in breast cancer. Therefore, it is reasonable to hypothesize that the miR-125b acts in different ways depending on the cellular context (Volinia et al., 2006) .
MiRs are known to regulate the expression of genes involved in the control of development, proliferation, apoptosis and stress response (He and Hannon, 2004) . Thus, we looked at the predicted targets of the downregulated miRs analysed in this study. Interestingly, the most used internet-based algorithms, Targetscan, Pictar and Miranda, identified among the regulated genes, also HMGA1 and HMGA2, as possible targets of miR-26a and miR-125b. These findings are very interesting since these proteins are expressed at very high levels in several malignant neoplasias (Tallini and Dal Cin, 1999; Fedele et al., 2001) and, in particular, in thyroid carcinomas (Chiappetta et al., 1995) . Moreover, our laboratory demonstrated that these proteins are really involved in the neoplastic process of thyroid carcinogenesis (Berlingieri et al., 2002) . Therefore, this is also consistent with the prediction of miR-125b and miR-26a as HMGA gene regulators since we showed that these two miRs are able to slow the cell proliferation rate once transfected in ATC cell lines. Studies are in progress in our laboratory to confirm this hypothesis.
In conclusion, this study indicates a miR signature associated with ATC and suggests a critical role of the miR-125b and miR-26a downregulation in thyroid carcinogenesis.
